LabCorp in talks to buy PPD for $8Bn

By Dani Bancroft contact

- Last updated on GMT

LabCorp in talks to buy the CRO PPD for $8Bn
Unconfirmed reports suggest Laboratory Corporation of America Holdings (LabCorp) is in talks to acquire contract research organization Pharmaceutical Product Development LLC (PPD).

According to a Reuters report​, a second party is taking part in the auction of PPD with LabCorp, but has not yet been identified​. 

If LabCorp was to acquire PPD, the transaction's value would exceed the $5.7bn for which it purchased Covance​ in 2015.

PPD offers contract research services from inhalation products to biologics​, for a wide range of indications, with headquarters in Wilmington, North Carolina. 

The firm has more than 18,500 employees worldwide and is owned by Carlyle Group LP and Hellman & Friedman LLC, which made the company private in 2011 for $3.9bn.

LabCorp is a North Carolina, US-based clinical lab network with a $14.3bn (€13.3bn) market cap. Last month, it acquired​ Mount Sinai’s clinical outreach laboratories, adding seven patient service centers to its network.

Related news

Show more

Related products

Ocopeptides

Advancing therapeutics for myeloma

Recipharm AB | 04-Sep-2017 | Case Study

Multiple myeloma is the second most common blood cancer in the world and despite survival rates increasing over the last decade, there remains a requirement...

Related suppliers